Efficacy and safety of osilodrostat in patients with Cushing's disease (LINC 3): a multicentre phase III study with a doubleblind, randomised withdrawal phase

Publication date: Available online 27 July 2020Source: The Lancet Diabetes & EndocrinologyAuthor(s): Rosario Pivonello, Maria Fleseriu, John Newell-Price, Xavier Bertagna, James Findling, Akira Shimatsu, Feng Gu, Richard Auchus, Rattana Leelawattana, Eun Jig Lee, Jung Hee Kim, André Lacroix, Audrey Laplanche, Paul O'Connell, Libuse Tauchmanova, Alberto M Pedroncelli, Beverly M K Biller, LINC 3 investigators
Source: The Lancet Diabetes and Endocrinology - Category: Endocrinology Source Type: research